Page last updated: 2024-08-16

temozolomide and n4-(2,2-dimethyl-3-oxo-4h-pyrid(1,4)oxazin-6-yl)-5-fluoro-n2-(3,4,5-trimethoxyphenyl)-2,4-pyrimidinediamine

temozolomide has been researched along with n4-(2,2-dimethyl-3-oxo-4h-pyrid(1,4)oxazin-6-yl)-5-fluoro-n2-(3,4,5-trimethoxyphenyl)-2,4-pyrimidinediamine in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, Z; Gu, J; Lin, Y; Liu, W; Liu, X; Lu, B; Lu, W; Mai, J; Mou, Y; Ou-Yang, Y; Sai, K; Sheng, L; Sun, S; Xing, F; Xue, D; Yan, G; Zhang, J; Zhu, W1

Other Studies

1 other study(ies) available for temozolomide and n4-(2,2-dimethyl-3-oxo-4h-pyrid(1,4)oxazin-6-yl)-5-fluoro-n2-(3,4,5-trimethoxyphenyl)-2,4-pyrimidinediamine

ArticleYear
R406 elicits anti-Warburg effect via Syk-dependent and -independent mechanisms to trigger apoptosis in glioma stem cells.
    Cell death & disease, 2019, 05-01, Volume: 10, Issue:5

    Topics: Animals; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Adhesion; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Glycolysis; Humans; Mice, Nude; Neoplastic Stem Cells; Oxazines; Oxidative Phosphorylation; Phosphatidylinositol 3-Kinases; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyridines; Signal Transduction; Survival Analysis; Syk Kinase; Temozolomide; Xenograft Model Antitumor Assays

2019